ANNOUNCEMENT: Important Changes to Borneo Journal of Pharmacy's Aims & Scope – Focused on Borneo's Research Excellence
Dear Esteemed Authors, Reviewers, and Readers,
We are delighted to share the exciting news that the Borneo Journal of Pharmacy (Borneo J Pharm) has recently achieved a significant milestone by being officially indexed in Scopus! This prestigious recognition is a testament to the quality and relevance of the research we publish, and we are profoundly grateful for the contributions of our dedicated authors, diligent reviewers, and supportive readers.
In light of this achievement and our commitment to further elevate research from and about Borneo Island, we are announcing an important refinement to the Aims & Scope of the Borneo Journal of Pharmacy, effective June 1st, 2025, or starting from Volume 8 Issue 3 2025.
Moving forward, the Borneo Journal of Pharmacy will exclusively focus on publishing research from authors affiliated with institutions on the Borneo Islands (Indonesia, Malaysia, and Brunei Darussalam), and/or research predominantly conducted within the Borneo Island region.
This strategic shift aims to:
- Strengthen the visibility and impact of research originating from Borneo.
- Foster collaboration and knowledge exchange among researchers within the Borneo region.
- Position Borneo Journal of Pharmacy as the leading platform for pharmaceutical research directly relevant to the unique context and challenges of Borneo.
Consequently, we regret to inform that, with the exception of collaborations as detailed below, we will no longer be able to accommodate new manuscript submissions from authors whose institutions are outside of Indonesia (in general) and, more specifically, outside of the Borneo Island region.
Exception for International Collaborations:
To continue promoting global scientific discourse while maintaining our core focus, we will consider manuscripts from authors outside the specified Borneo region only if the research involves a genuine and active collaboration with researchers affiliated with institutions on Borneo Island. This means the partnership should extend beyond joint authorship and involve substantive joint research efforts conducted by researchers from both parties. Evidence of such collaboration, including methodological contributions, data collection, or significant intellectual input from Borneo-based researchers, will be required.
We understand that this change may impact some of our previous contributors, and we sincerely apologize for any inconvenience this may cause. This decision has been made to better serve our mission and to maximize the regional and global impact of Borneo-focused pharmaceutical science.
We encourage all researchers from or collaborating with institutions on Borneo Island to continue submitting their high-quality work to us. We look forward to receiving your valuable contributions as we embark on this exciting new phase.
For any inquiries regarding these changes, please do not hesitate to contact our editorial office at bjop@umpr.ac.id.
Sincerely,
The Editorial Board of Borneo Journal of Pharmacy